MORGUARD LINCLUDEN GLOBAL INVESTMENTS Ltd historic quarter change: Foreign Stocks, Reduced
In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 23 quarters from 2013-06-30 to 2026-06-30, MORGUARD LINCLUDEN GLOBAL INVESTMENTS Ltd opened 8 positions, added to 72, reduced 80 and sold out of 8.
- Q2 2026: Stock SAP; Country of operation —; Class SPON ADR; Shares before 29,833.
- Q2 2026: Stock ING; Country of operation —; Class SPON ADR; Shares before 218,394.
- Q2 2026: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 114,963.
- Q2 2026: Stock GSK; Country of operation —; Class COM; Shares before 58,371.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1058231), 23 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-07-24); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-13); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-01-30); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-11-14); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-25); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-06); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-02-04); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-28); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-24); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-17); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-23); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-04-21); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-02-12); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-11-09); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-31); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-05-05); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-02-19); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-11-21); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-18); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-04-16); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-11); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-13). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2006-03-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).
| Quarter | Stock | Country of operation | Class | Shares before | Shares after | Share change | Value before | Value after | Value change | Filed |
|---|
| Q2 2026 | SAP
SAP SE | | SPON ADR | 29,833 | 15,362 | -14,471 | $5,107 | $2,367 | -$2,740 | 2026-07-24 |
|---|
| Q2 2026 | ING
ING GROEP N V | | SPON ADR | 218,394 | 209,457 | -8,937 | $5,689 | $6,573 | +$884 | 2026-07-24 |
|---|
| Q2 2026 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 114,963 | 95,951 | -19,012 | $8,558 | $7,713 | -$845 | 2026-07-24 |
|---|
| Q2 2026 | GSK
GSK PLC | | COM | 58,371 | 57,400 | -971 | $3,221 | $3,009 | -$212 | 2026-07-24 |
|---|
| Q1 2026 | GRTUF
GRANITE REAL ESTATE INVT TR | Canada | TR UNIT NEW | 112,144 | 104,627 | -7,517 | $9,163 | $6,247 | -$2,916 | 2026-05-13 |
|---|
| Q1 2026 | SHEL
SHELL PLC | | SPON ADR | 40,518 | 33,038 | -7,480 | $2,977 | $3,072 | +$95 | 2026-05-13 |
|---|
| Q4 2025 | SAP
SAP SE | | SPON ADR | 27,439 | 27,410 | -29 | $7,332 | $6,658 | -$674 | 2026-01-30 |
|---|
| Q4 2025 | ING
ING GROEP N V | | SPON ADR | 227,259 | 208,280 | -18,979 | $5,927 | $5,832 | -$95 | 2026-01-30 |
|---|
| Q3 2025 | ING
ING GROEP N V | | SPON ADR | 238,040 | 227,259 | -10,781 | $5,206 | $5,927 | +$721 | 2025-11-14 |
|---|
| Q3 2025 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 58,026 | 57,835 | -191 | $5,851 | $5,519 | -$332 | 2025-11-14 |
|---|
| Q3 2025 | GSK
GSK PLC | | SPONSORED ADR | 62,020 | 61,480 | -540 | $2,382 | $2,653 | +$271 | 2025-11-14 |
|---|
| Q3 2025 | SHEL
SHELL PLC | | W/ ADR | 44,138 | 43,956 | -182 | $3,108 | $3,144 | +$36 | 2025-11-14 |
|---|
| Q2 2025 | ING
ING GROEP N V | | SPON ADR | 248,061 | 238,040 | -10,021 | $4,860 | $5,206 | +$346 | 2025-07-25 |
|---|
| Q2 2025 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 58,498 | 58,026 | -472 | $6,130 | $5,851 | -$279 | 2025-07-25 |
|---|
| Q2 2025 | SHEL
SHELL PLC | | W/ ADR | 44,874 | 44,138 | -736 | $3,288 | $3,108 | -$180 | 2025-07-25 |
|---|
| Q2 2025 | SAP
SAP SE | | SPON ADR | 5,170 | 5,106 | -64 | $1,388 | $1,553 | +$165 | 2025-07-25 |
|---|
| Q2 2025 | GSK
GSK PLC | | SPONSORED ADR | 66,128 | 62,020 | -4,108 | $2,236 | $2,382 | +$146 | 2025-07-25 |
|---|
| Q2 2025 | ORANY
ORANGE | France | SPON ADR | 284,920 | 238,840 | -46,080 | $3,692 | $3,621 | -$71 | 2025-07-25 |
|---|
| Q1 2025 | ORANY
ORANGE | France | SPON ADR | 290,392 | 284,920 | -5,472 | $2,895 | $3,692 | +$797 | 2025-05-06 |
|---|
| Q1 2025 | SAP
SAP SE | | SPON ADR | 5,395 | 5,170 | -225 | $1,328 | $1,388 | +$60 | 2025-05-06 |
|---|
| Q1 2025 | ING
ING GROEP N V | | SPON ADR | 311,647 | 248,061 | -63,586 | $4,884 | $4,860 | -$24 | 2025-05-06 |
|---|
| Q4 2024 | ING
ING GROEP N V | | SPON ADR | 314,117 | 311,647 | -2,470 | $5,704 | $4,884 | -$820 | 2025-02-04 |
|---|
| Q4 2024 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 58,070 | 57,739 | -331 | $8,150 | $7,340 | -$810 | 2025-02-04 |
|---|
| Q4 2024 | SAP
SAP SE | | SPON ADR | 6,476 | 5,395 | -1,081 | $1,484 | $1,328 | -$156 | 2025-02-04 |
|---|
| Q3 2024 | SAP
SAP SE | | SPON ADR | 6,485 | 6,476 | -9 | $1,308 | $1,484 | +$176 | 2024-10-28 |
|---|
| Q3 2024 | ORANY
ORANGE | France | SPON ADR | 322,909 | 290,222 | -32,687 | $3,226 | $3,332 | +$106 | 2024-10-28 |
|---|
| Q2 2024 | DEO
DIAGEO PLC-SPONS ADR | | SPON ADR NEW | 51,240 | 50,600 | -640 | $7,464 | $6,380 | -$1,084 | 2024-07-24 |
|---|
| Q2 2024 | SAP
SAP SE | | SPON ADR | 9,273 | 6,485 | -2,788 | $1,808 | $1,308 | -$500 | 2024-07-24 |
|---|
| Q2 2024 | GSK
GSK PLC | | SPONSORED ADR | 65,252 | 65,168 | -84 | $2,797 | $2,509 | -$288 | 2024-07-24 |
|---|
| Q2 2024 | ING
ING GROEP N V | | SPON ADR | 317,882 | 311,475 | -6,407 | $5,242 | $5,339 | +$97 | 2024-07-24 |
|---|
| Q1 2024 | ING
ING GROEP N V | | SPON ADR | 321,378 | 317,882 | -3,496 | $4,827 | $5,242 | +$415 | 2024-05-07 |
|---|
| Q1 2024 | GSK
GSK PLC | | SPONSORED ADR | 65,975 | 65,252 | -723 | $2,445 | $2,797 | +$352 | 2024-05-07 |
|---|
| Q1 2024 | SAP
SAP SE | | SPON ADR | 9,545 | 9,273 | -272 | $1,476 | $1,808 | +$332 | 2024-05-07 |
|---|
| Q1 2024 | ORANY
ORANGE | France | SPON ADR | 271,074 | 268,004 | -3,070 | $3,098 | $3,154 | +$56 | 2024-05-07 |
|---|
| Q1 2024 | VOD
VODAFONE GROUP PLC | | SPON ADR | 283,911 | 280,064 | -3,847 | $2,470 | $2,493 | +$23 | 2024-05-07 |
|---|
| Q3 2016 | ING
ING GROEP N V | | SPON ADR | 255,118 | 229,473 | -25,645 | $2,635,000 | $2,832,000 | +$197,000 | 2016-11-17 |
|---|
| Q1 2016 | SAP
SAP SE | | SPON ADR | 86,928 | 86,833 | -95 | $6,876,000 | $6,983,000 | +$107,000 | 2016-04-21 |
|---|
| Q4 2015 | ULXXXX
UNILEVER | | SPON ADR | 166,640 | 6,190 | -160,450 | $4,562,000 | $267,000 | -$4,295,000 | 2016-02-12 |
|---|
| Q4 2015 | SAP
SAP SE | | SPON ADR | 88,023 | 86,928 | -1,095 | $5,703,000 | $6,876,000 | +$1,173,000 | 2016-02-12 |
|---|
| Q4 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 47,090 | 45,780 | -1,310 | $2,659,000 | $3,005,000 | +$346,000 | 2016-02-12 |
|---|
| Q4 2015 | ORANY
ORANGE | France | SPON ADR | 148,081 | 142,841 | -5,240 | $2,239,000 | $2,375,000 | +$136,000 | 2016-02-12 |
|---|
| Q3 2015 | ING
ING GROEP N V | | SPON ADR | 255,864 | 235,439 | -20,425 | $4,242,000 | $3,327,000 | -$915,000 | 2015-11-09 |
|---|
| Q3 2015 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 100,318 | 99,998 | -320 | $2,095,000 | $1,767,000 | -$328,000 | 2015-11-09 |
|---|
| Q3 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 50,030 | 47,090 | -2,940 | $2,957,000 | $2,659,000 | -$298,000 | 2015-11-09 |
|---|
| Q3 2015 | BCS
BARCLAYS PLC | | ADR | 149,322 | 148,832 | -490 | $2,455,000 | $2,200,000 | -$255,000 | 2015-11-09 |
|---|
| Q3 2015 | SNY
SANOFI AVENTIS | | SPON ADR | 47,782 | 47,632 | -150 | $2,367,000 | $2,261,000 | -$106,000 | 2015-11-09 |
|---|
| Q3 2015 | ORANY
ORANGE | France | SPON ADR | 148,541 | 148,081 | -460 | $2,282,000 | $2,239,000 | -$43,000 | 2015-11-09 |
|---|
| Q2 2015 | ORANY
ORANGE | France | SPON ADR | 470,271 | 148,541 | -321,730 | $7,529,000 | $2,282,000 | -$5,247,000 | 2015-07-31 |
|---|
| Q2 2015 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 67,540 | 50,030 | -17,510 | $4,208,000 | $2,957,000 | -$1,251,000 | 2015-07-31 |
|---|
| Q2 2015 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 130,223 | 100,318 | -29,905 | $2,757,000 | $2,095,000 | -$662,000 | 2015-07-31 |
|---|
| Q2 2015 | SAP
SAP SE | | SPON ADR | 49,923 | 42,078 | -7,845 | $3,603,000 | $2,955,000 | -$648,000 | 2015-07-31 |
|---|
| Q2 2015 | SNY
SANOFI AVENTIS | | SPON ADR | 59,617 | 47,782 | -11,835 | $2,947,000 | $2,367,000 | -$580,000 | 2015-07-31 |
|---|
| Q2 2015 | BCS
BARCLAYS PLC | | ADR | 193,852 | 149,322 | -44,530 | $2,824,000 | $2,455,000 | -$369,000 | 2015-07-31 |
|---|
| Q2 2015 | ING
ING GROEP N V | | SPON ADR | 304,024 | 255,864 | -48,160 | $4,442,000 | $4,242,000 | -$200,000 | 2015-07-31 |
|---|
| Q1 2015 | ORANY
ORANGE | France | SPON ADR | 693,416 | 470,271 | -223,145 | $11,733,000 | $7,529,000 | -$4,204,000 | 2015-05-05 |
|---|
| Q1 2015 | BCS
BARCLAYS PLC | | ADR | 209,022 | 193,852 | -15,170 | $3,137,000 | $2,824,000 | -$313,000 | 2015-05-05 |
|---|
| Q1 2015 | ING
ING GROEP N V | | SPON ADR | 322,644 | 304,024 | -18,620 | $4,185,000 | $4,442,000 | +$257,000 | 2015-05-05 |
|---|
| Q1 2015 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 139,703 | 130,223 | -9,480 | $2,955,000 | $2,757,000 | -$198,000 | 2015-05-05 |
|---|
| Q1 2015 | SNY
SANOFI AVENTIS | | SPON ADR | 63,527 | 59,617 | -3,910 | $2,897,000 | $2,947,000 | +$50,000 | 2015-05-05 |
|---|
| Q1 2015 | ULXXXX
UNILEVER PLC | | SPON ADR | 6,700 | 6,190 | -510 | $271,000 | $258,000 | -$13,000 | 2015-05-05 |
|---|
| Q4 2014 | ORANY
ORANGE | France | SPON ADR | 702,196 | 693,416 | -8,780 | $10,350,000 | $11,733,000 | +$1,383,000 | 2015-02-19 |
|---|
| Q4 2014 | ING
ING GROEP N V | | SPON ADR | 390,874 | 322,644 | -68,230 | $5,547,000 | $4,185,000 | -$1,362,000 | 2015-02-19 |
|---|
| Q4 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 80,923 | 53,670 | -27,253 | $4,350,000 | $3,087,000 | -$1,263,000 | 2015-02-19 |
|---|
| Q4 2014 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 143,128 | 139,703 | -3,425 | $3,207,000 | $2,955,000 | -$252,000 | 2015-02-19 |
|---|
| Q4 2014 | SAP
SAP AG | | SPON ADR | 38,263 | 37,318 | -945 | $2,761,000 | $2,599,000 | -$162,000 | 2015-02-19 |
|---|
| Q4 2014 | BCS
BARCLAYS PLC | | ADR | 214,267 | 209,022 | -5,245 | $3,173,000 | $3,137,000 | -$36,000 | 2015-02-19 |
|---|
| Q3 2014 | ULXXXX
UNILEVER PLC | | SPON ADR | 6,815 | 6,700 | -115 | $309,000 | $280,000 | -$29,000 | 2014-11-21 |
|---|
| Q2 2014 | SIEGY
SIEMENS AG | | SPON ADR | 25,679 | 24,274 | -1,405 | $3,471,000 | $3,219,000 | -$252,000 | 2014-07-18 |
|---|
| Q2 2014 | ULXXXX
UNILEVER PLC | | SPON ADR | 7,860 | 6,815 | -1,045 | $336,000 | $309,000 | -$27,000 | 2014-07-18 |
|---|
| Q1 2014 | TEVA
TEVA PHARMACEUTICAL INDS LTD. | | ADR | 80,098 | 69,596 | -10,502 | $3,210,000 | $3,677,000 | +$467,000 | 2014-04-16 |
|---|
| Q1 2014 | ING
ING GROEP N V | | SPON ADR | 357,720 | 356,034 | -1,686 | $5,012,000 | $5,073,000 | +$61,000 | 2014-04-16 |
|---|
| Q4 2013 | ORANY
ORANGE | France | SPON ADR | 736,856 | 664,036 | -72,820 | $9,218,000 | $8,201,000 | -$1,017,000 | 2014-02-11 |
|---|
| Q4 2013 | PBR
PETROLEO BRASILEIRO | | SPON ADR | 114,080 | 101,835 | -12,245 | $1,767,000 | $1,403,000 | -$364,000 | 2014-02-11 |
|---|
| Q4 2013 | SIEGY
SIEMENS AG | | SPON ADR | 26,734 | 23,349 | -3,385 | $3,222,000 | $3,234,000 | +$12,000 | 2014-02-11 |
|---|
| Q3 2013 | ING
ING GROEP N V | | SPON ADR | 350,805 | 339,540 | -11,265 | $3,189,000 | $3,854,000 | +$665,000 | 2013-11-13 |
|---|
| Q3 2013 | SNY
SANOFI AVENTIS | | SPON ADR | 47,853 | 43,583 | -4,270 | $2,465,000 | $2,207,000 | -$258,000 | 2013-11-13 |
|---|
| Q3 2013 | BCS
BARCLAYS PLC | | ADR | 172,225 | 166,758 | -5,467 | $2,948,000 | $2,842,000 | -$106,000 | 2013-11-13 |
|---|
| Q3 2013 | PBR
PETROLEO BRASILEIRO | | SPON ADR | 125,710 | 114,080 | -11,630 | $1,686,000 | $1,767,000 | +$81,000 | 2013-11-13 |
|---|
| Q3 2013 | ABBNY
ABB LTD. | Switzerland | SPON ADR | 120,053 | 110,903 | -9,150 | $2,600,000 | $2,616,000 | +$16,000 | 2013-11-13 |
|---|
| Q3 2013 | SIEGY
SIEMENS AG | | SPON ADR | 31,944 | 26,734 | -5,210 | $3,236,000 | $3,222,000 | -$14,000 | 2013-11-13 |
|---|